Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YFQLXB-UC01 intravenous infusion for decompensated cirrhosis
CTR20241765Phase 2Active
- Sponsor
- Qilu Cell Therapy
- Start
- Jul 2024
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of umbilical cord mesenchymal stem cells (Shandong Province Qilu Stem Cells Engineering) in Cirrhosis, sponsored by Qilu Cell Therapy. Started Jul 2024; status: active.
02
Drugs
umbilical cord mesenchymal stem cells (Shandong Province Qilu Stem Cells Engineering)
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on CTR20241765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241765.